insights_auto
Why is ORX down 3.08%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 0.85
arrow_downward
-3.08%(-0.027) 1D
Nov 16, 2:25:48 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
297.56M
Avg. vol.
777.72K
Volume
341.71K
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
297.56M
Avg. vol.
777.72K
Volume
341.71K
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Yahoo Finance
·
27 minutes ago
Nearly a fifth of the S&P 500 is tied to three men with no clear successors
Investing.com
·
33 minutes ago
Dow Jones, Nasdaq, S&P 500 weekly preview: Nvidia earnings, Anthropic IPO on deck
Business Insider
·
3 hours ago
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
FXEmpire
·
18 minutes ago
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com